Cargando…
A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia
The aim of this study was to assess the potential impact of the kinetics of serum levels of seven cytokines during induction in acute myeloid leukemia (AML) patients. Indeed, the role of cytokines, in the pathophysiology and response to therapy of AML patients, remains under investigation. Here, we...
Autores principales: | Peterlin, Pierre, Gaschet, Joelle, Guillaume, Thierry, Garnier, Alice, Eveillard, Marion, Le Bourgeois, Amandine, Cherel, Michel, Debord, Camille, Le Bris, Yannick, Theisen, Olivier, Godon, Catherine, Mahé, Béatrice, Dubruille, Viviane, Wuilleme, Soraya, Touzeau, Cyrille, Gastinne, Thomas, Blin, Nicolas, Lok, Anne, Tessoulin, Benoît, Le Gouill, Steven, Moreau, Philippe, Béné, Marie‐C, Chevallier, Patrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877358/ https://www.ncbi.nlm.nih.gov/pubmed/33369136 http://dx.doi.org/10.1002/cam4.3648 |
Ejemplares similares
-
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft
por: Jullien, Maxime, et al.
Publicado: (2020) -
Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies
por: Chevallier, Patrice, et al.
Publicado: (2018) -
Interest of a Third Dose of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Stem-Cells Recipients
por: Le Bourgeois, Amandine, et al.
Publicado: (2021) -
Antibody Response after One and/or Two Doses of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy
por: Gastinne, Thomas, et al.
Publicado: (2021) -
B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
por: Jullien, Maxime, et al.
Publicado: (2022)